Ex vivo supplementation of T cells from UC patients with GlcNAc promoted branched N-glycans in the TCR leading to suppression of pro-inflammatory responses and control of T-cell activity [22].Additionally, LGALS9, a gene that encodes for human galectin-9, was also found to be associated with IBD. This evidence concerns the gene LGALS9 and inflammatory bowel disease.